[{"Assets_0_Q2_USD":1482652000.0,"CommonStockSharesOutstanding_0_Q2_shares":122604714.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-64036000.0,"NetIncomeLoss_1_Q2_USD":-36387000.0,"NetIncomeLoss_2_Q2_USD":-75811000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":102894000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":193190000.0,"StockholdersEquity_0_Q2_USD":744388000.0,"Ticker":"EXAS","CIK":"1124140","name":"EXACT SCIENCES CORP","OfficialName":"Exact Sciences Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12010562930.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180801"}]